Home
Home

R&D

Pharma's R&D Deals With Foundations May Negatively Impact Image

Pharma's R&D Deals With Foundations May Negatively Impact Image
Forbes

Sanofi, France remain at odds over fate of 600 R&D jobs

Sanofi, France remain at odds over fate of 600 R&D jobs
Fierce Pharma

Bristol-Myers, Merck And Roche: R&D Finds Golden Pill, So Buy

Bristol-Myers, Merck And Roche: R&D Finds Golden Pill, So Buy
Seeking Alpha

Bristol-Myers Targets Heart-Failure Drugs in R&D Effort

Bristol-Myers Targets Heart-Failure Drugs in R&D Effort
Bloomberg

Quintiles, Merck Serono announce clinical development partnership

Quintiles, Merck Serono announce clinical development partnership
Yahoo/Fly on the Wall

A Culture Change? AbbVie R&D Chief To Retire

A Culture Change? AbbVie R&D Chief To Retire
Pharmalot

Merck spotlights new deals, R&D review as demands to rebuild pipeline grow

Merck spotlights new deals, R&D review as demands to rebuild pipeline grow
Fierce Biotech

What The Pfizer-Merck Diabetes Deal Teaches About Today's Pharma R&D

What The Pfizer-Merck Diabetes Deal Teaches About Today's Pharma R&D
Forbes

MedImmune chief taps top prospects, hunts new biologics deals

MedImmune chief taps top prospects, hunts new biologics deals
Fierce Biotech

FDA Discouraging Real-Time Release Testing as a Shortcut to End Testing, Experts Say

FDA Discouraging Real-Time Release Testing as a Shortcut to End Testing, Experts Say
in-Pharma Technologist